Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4 - Full Text View

Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Texas
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000307

Purpose

The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.

Condition	Intervention	Phase
Alcohol-Related Disorders Cocaine-Related Disorders	Drug: Naltrexone	Phase II

ChemIDplus related topics:

Naltrexone 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride Naltrexone hydrochloride

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Verified abstinence from cocaine [ Time Frame: over the 12 weeks of study ] [ Designated as safety issue: No ]

Estimated Enrollment:	0
Study Start Date:	April 2003
Study Completion Date:	April 2007
Primary Completion Date:	April 2007 (Final data collection date for primary outcome measure)

Eligibility

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000307

Locations


United States, Texas
	University of Texas Health Science Center
	Houston, Texas, United States, 77225

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Texas

Investigators


Principal Investigator:	John Grabowski, Ph.D.	University of Texas

More Information

Responsible Party:	University of Texas Medical School at Houston ( Joy Schmitz, Ph.D. )
Study ID Numbers:	NIDA-09262-4, P50-09262-4
First Received:	September 20, 1999
Last Updated:	August 11, 2008
ClinicalTrials.gov Identifier:	NCT00000307
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Cocaine-Related Disorders

Mental Disorders

Naltrexone

Substance-Related Disorders

Disorders of Environmental Origin

Alcohol-Related Disorders

Cocaine

Additional relevant MeSH terms:

Pathologic Processes

Disease

Sensory System Agents

Therapeutic Uses

Physiological Effects of Drugs

Narcotic Antagonists

Peripheral Nervous System Agents

Central Nervous System Agents

Pharmacologic Actions

ClinicalTrials.gov processed this record on August 20, 2008